16
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial.

      Lancet (London, England)

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Previous trials of antiplatelet therapy for the prevention of venous thromboembolism have individually been inconclusive, but a meta-analysis of their results indicated reductions in the risks of deep-vein thrombosis and of pulmonary embolism in various high-risk groups. The aim of this large randomised placebo-controlled trial was to confirm or refute these apparent benefits.

          Related collections

          Author and article information

          Journal
          Lancet
          Lancet (London, England)
          0140-6736
          0140-6736
          Apr 15 2000
          : 355
          : 9212
          Article
          S0140673600021103
          10.1016/S0140-6736(00)02110-3
          10776741
          6458bf24-d4d1-4982-8d6f-2470f4e3f334
          History

          Comments

          Comment on this article